Innovatiefonds MKB+ has made the first venture investment in Dutch biotech company Aeon Astron Europe.
The new equity will be used to support the company's expansion plans, including the addition of seven labs and a clean room, as well as an increase in the number of staff. The funding will also support...
Fund's predecessor, Capzanine 3, also closed on its €350m hard-cap in 2013
Deal follows a similar investment in the oil exploration business earlier this year
Adveq invests €10m, while HPE Growth Capital provided the initial €20m in May
Palamon reaps €140m in proceeds for a 3x money return following the sale to PAI